You have 9 free searches left this month | for more free features.

Condition

Diffuse Cutaneous Systemic Sclerosis (1)

Lupus (1)

SLE (1)

Systemic Lupus Erythematosus (1)

Overall Status

Completed (1)

Terminated (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

Corbus Pharmaceuticals Inc. (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Autoimmunity Centers of Excellence (1)

Corbus Pharmaceuticals Inc. (1)

Rho Federal Systems Division, Inc. (1)

Intervention

jbt-101 (2)

placebo (2)

part b open-label extension (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

NIH (1)

Study Type

Interventional (2)

jbt-101

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Systemic Lupus Erythematosus, SLE, Lupus Trial in United States (JBT-101, Placebo)

Completed

Has Results

Systemic Lupus Erythematosus
+2 more

JBT-101
Placebo

La Jolla, California
+15 more

Oct 27, 2022

Diffuse Cutaneous Systemic Sclerosis Trial in United States (JBT-101, Placebo, Part B Open-Label Extension)

Terminated

Has Results

Diffuse Cutaneous Systemic Sclerosis

JBT-101
+2 more

Los Angeles, California
+8 more

Mar 25, 2021